A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy

DOI: 10.1186/s13044-017-0041-6

Keywords: Medullary thyroid carcinoma, Vandetinib, Cabozantinib, Population-based, Tyrosine kinase inhibitors

Full-Text   Cite this paper   Add to My Lib

Abstract:

Baseline MTC patient characteristic

Full-Text